EMEA recommends strengthening warnings and contraindications for etoricoxib-containing medicines used in the treatment of rheumatoid arthritis and ankylosing spondylitis

View source ↗

Summary

EMA recommends stronger warnings and contraindications for etoricoxib-containing medicines used to treat rheumatoid arthritis and ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Rheumatoid Arthritis

Drugs mentioned

• etoricoxib-containing medicines (etoricoxib)